作者: David Gutmann , Jason Weber
DOI:
关键词:
摘要: This invention is directed generally to methods for treating neurofibromatosis 1 (NF1), and, more particularly, NF1 by administering rapamycin, a rapamycin analog, prodrug, or salt of the analog prodrug. also compositions and kits NF1, that comprise